Nano-bio-technology  |  Chemistry   |  Semiconductors

Altratech Home2021-11-26T09:53:32+00:00

Next Generation Molecular Detection

Discover Altratech

Next Generation Molecular Detection

Discover Altratech

At Altratech, our mission is to enable next generation molecular detection.

This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.

At Altratech, our mission is to enable next generation molecular detection.

This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.

KeyChain PNA

Altratech uses PNA Technology to address the fundamental complication of extracting genetic material from a biological sample. KeyChain PNA offers a purely synthetic alternative to biotinylation; it is reversible, tuneable, and programmable. KeyChain PNA will enable users to both multiplex and simplify sample preparation applications in a way which is not currently possible.

Learn More

BioSensing

At Altratech, we use fringe-field capacitive sensing to quantify molecular targets. These sensors which sit in the top layer of a standard CMOS chip, detect the beads (magnetic, non-magnetic, gold, or silver nanoparticles) associated with a target. The surface of the sensor is also functionalised with PNA technology to enable multiplexing and robust detection.

Learn More

Detection by Proxy

PCR is viewed as the gold standard for interrogating RNA and DNA; however, Detection by Proxy differs in that RNAs of interest are transduced into coded nanoparticles and are read by a semiconductor sensor. The RNA is purified in the process but is not modified or copied in any way. By definition, Detection by Proxy can be used with other targets such as antibodies and antigens
Learn More

Any Person. Anywhere. Any Sample.

Altratech – Next Generation Molecular Detection

About Altratech

We are a team of seventeen scientists and engineers (molecular biology, surface chemistry, microfluidics, and chip design) bringing together nano biotechnology, chemistry, and semiconductors to radically change the accessibility of high content genetic data. We have been working together since 2016 on the development of this ground-breaking science

We are creating an infrastructure of technology and data to manage contagious viral diseases, important for the future of decentralised connected healthcare and wellbeing.

Based on the novel Detection by Proxy concept, Altratech has developed the next generation of molecular detection. The technology enables any person, anywhere, to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples.

Learn More

In the News

Altratech presents at NextGenDx 2020

At NextGenDx conference (Aug 2020), Altratech presented “Novel Techniques for POC Disease Monitoring Utilizing Programmable Molecular Velcro” These advanced PNA probes were co-developed by Altratech and NIH, and jointly filed in a US patent disclosure

More Stories

Our Investors

Our Investors

Go to Top